Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients-Reference-Cited by-同舟云学术

Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients

Published:2016-04 Issue:2 Volume:30 Page:418-422
ISSN:1053-0770
Container-title:Journal of Cardiothoracic and Vascular Anesthesia
language:en
Short-container-title:Journal of Cardiothoracic and Vascular Anesthesia

Author:

Shibata Sho C.,Uchiyama Akinori^ORCID,Ohta Noriyuki,Fujino Yuji

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery;Arsenault;Cochrane Database Syst Rev,2013

2. Acute management of atrial fibrillation;Khoo;Chest,2009

3. Clinical review: Treatment of new-onset atrial fibrillation in medical intensive care patients – a clinical framework;Sleeswijk;Crit Care,2007

4. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;January;Circulation,2014

5. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association;Camm;Europace,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Chronic Oral Beta-Blocker Intake on Intravenous Bolus Landiolol Response in Hospitalized Intensive Care Patients with Sudden-Onset Supraventricular Tachycardia—A Post Hoc Analysis of a Cross-Sectional Trial;Pharmaceutics;2024-06-20

2. Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review;Journal of Clinical Medicine;2024-05-17

3. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation;Pharmaceutics;2024-04-08

4. Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial;Trials;2023-05-25

5. Effects of Landiolol on Macrocirculatory Parameters and Left and Right Ventricular Performances Following Cardiac Surgery: A Randomized Controlled Trial;Journal of Cardiothoracic and Vascular Anesthesia;2022-08